EDSA: Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026
On December 12, 2025, Edesa Biotech, Inc. (EDSA) announced financial results for fiscal year 2025 that ended September 30, 2025 and provided a...
238 Views
LGND: 2025 Analyst Day
Ligand Pharmaceuticals holds a portfolio of revenue, royalty & milestone generating assets that have been vetted by its internal investment...
251 Views
MTVA: New Data for Vanoglipel (DA-1241) Presented at AASLD
In November 2025, MetaVia Inc. (MTVA) announced new positive data from the Phase 2a clinical trial of vanoglipel (DA-1241) was presented at the...
291 Views
Our valuation is based on a NAV analysis for the Company based on its 55% ownership in the Buckreef Gold Mine
TRX Gold Corporation is a junior gold producer operating the Buckreef Gold Mine in Tanzania under a joint venture with the state mining...
303 Views
MTVA: New Date for Vanoglipel (DA-1241) Presented at AASLD
In November 2025, MetaVia Inc. (MTVA) announced new positive data from the Phase 2a clinical trial of vanoglipel (DA-1241) was presented at the...
247 Views